This is a step in the right direction.
The U.S. Food and Drug Administration will hold its first public hearing Friday into how it should regulate CBD products, and it may end up limiting how much of the cannabis compound can be included in food and drinks.
“What they might end up doing is reserve the higher dosages of CBD for pharmaceutical drugs and only permit lower dosages to be incorporated in food and drinks. That in itself would hopefully keep an incentive for the pharmaceutical companies to continue to invest in clinical research.”
The full story is here:
U.S. Reviews CBD Amid Pressure to Act Quickly: Cannabis Weekly – Bloomberg